| Literature DB >> 31860218 |
Erik L. Peterson, Daniel Gutierrez, Nooshin K. Brinster, Kristen I. Lo Sicco, Jerry Shapiro.
Abstract
Lichen planopilaris (LPP) is a cicatricial alopecia that often causes permanent hair loss. Pioglitazone, a peroxisome proliferator activated receptor-gamma (PPAR- γ) agonist, has demonstrated immunomodulatory properties that may offer an effective treatment modality. This retrospective analysis describes 23 patients with LPP treated with adjunctive pioglitazone. Most (18/25) demonstrated significant reduction in patient-reported symptoms and clinical signs of inflammation. No adverse effects were reported. J Drugs Dermatol. 2019;18(12):1276-1279.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31860218
Source DB: PubMed Journal: J Drugs Dermatol ISSN: 1545-9616 Impact factor: 2.114